About this item
Product details
Management of type 2 diabetes mellitus to improve glycemic control as an adjunct to diet and exercise. Reduces the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease. Helps in weight management and improving renal outcomes in patients with diabetes. Empagliflozin is a medication used to treat patients with type 2 diabetes mellitus. It is typically administered as a tablet taken once a day, with or without food. These tablets inhibit the enzyme sodium-glucose cotransporter-2, which ultimately reduces blood sugar levels within the body. Alongside its glucose-inhibiting properties, empagliflozin also promotes weight loss and prevents cardiovascular disease. By reducing glucose absorption and encouraging the excretion of excess sodium and water, the drug decreases body weight. In terms of cardiovascular disease prevention, the medication improves cholesterol levels and reduces the risk of heart-related complications in those with type 2 diabetes.It is important to follow medical advice and guidelines when taking empagliflozin. Consultation with a licensed medical practitioner is necessary to ensure the regime aligns with individual health needs. This information is a simplified version and should not replace professional medical advice. Composition Each film coated tablet contains: Empagliflozin: 25 mg Linagliptin: 5 mg Directions for Use As recommended by a registered medical practitioner.
- Medicine
- 14 Film Coated Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicine
- Brand
- Ferozsons
- SKU
- 08961100514571
- Variant
- 14 Film Coated Tablets
- Tags
- Empagliflozin, Linagliptin, Medicine, Type 2 Diabetes
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
